Immunohistochemistry Market – Companion Diagnostic IHC...

added blog Health

2026-08-05 11:13:19 -

Immunohistochemistry Market – Companion Diagnostic IHC Guiding Precision Oncology Therapy Selection

Market Overview The immunohistochemistry market is strengthening as companion diagnostic IHC guides precision oncology therapy selection, providing predictive biomarker assessment that determines patient eligibility for targeted therapies including HER2-directed breast cancer treatment, PD-1/PD-L1 immune checkpoint inhibitors, ALK-rearranged lung cancer tyrosine kinase inhibitors, and mismatch...

0 Comments 0 Shares 12 Views 0 Reviews